Skip to main content

Want a detailed portfolio tracker?

Comparison Iterum Therapeutics (ITRM) with Competitors

Iterum Therapeutics (ITRM) industry is Biotechnology.

Debt-to-Equity
ITRM-271.58%
Industry29.76%
Upside-301.33%
P/E
ITRM-0.22
Industry-18.88
Upside+1866.02%